| The applicability of pharmaceutical polymeric blends for the fused deposition modelling (FDM) 3D technique: Material considerations–printability–process modulation, with … K Ilyés, NK Kovács, A Balogh, E Borbás, B Farkas, T Casian, G Marosi, ... European Journal of Pharmaceutical Sciences 129, 110-123, 2019 | 176 | 2019 |
| In-line Raman spectroscopic monitoring and feedback control of a continuous twin-screw pharmaceutical powder blending and tableting process B Nagy, A Farkas, M Gyürkés, S Komaromy-Hiller, B Démuth, B Szabó, ... International journal of pharmaceutics 530 (1-2), 21-29, 2017 | 126 | 2017 |
| Application of artificial neural networks for Process Analytical Technology-based dissolution testing B Nagy, D Petra, DL Galata, B Démuth, E Borbás, G Marosi, ZK Nagy, ... International journal of pharmaceutics 567, 118464, 2019 | 107 | 2019 |
| Investigation and mathematical description of the real driving force of passive transport of drug molecules from supersaturated solutions E Borbas, B Sinkó, O Tsinman, K Tsinman, É Kiserdei, B Démuth, ... Molecular pharmaceutics 13 (11), 3816-3826, 2016 | 106 | 2016 |
| In vitro dissolution–permeation evaluation of an electrospun cyclodextrin-based formulation of aripiprazole using μFlux™ E Borbás, A Balogh, K Bocz, J Müller, É Kiserdei, T Vigh, B Sinkó, ... International journal of pharmaceutics 491 (1-2), 180-189, 2015 | 86 | 2015 |
| Raman spectroscopy for process analytical technologies of pharmaceutical secondary manufacturing B Nagy, A Farkas, E Borbás, P Vass, ZK Nagy, G Marosi Aaps Pharmscitech 20 (1), 1, 2018 | 82 | 2018 |
| AC and DC electrospinning of hydroxypropylmethylcellulose with polyethylene oxides as secondary polymer for improved drug dissolution A Balogh, B Farkas, G Verreck, J Mensch, E Borbás, B Nagy, G Marosi, ... International Journal of Pharmaceutics 505 (1-2), 159-166, 2016 | 75 | 2016 |
| Detailed stability investigation of amorphous solid dispersions prepared by single-needle and high speed electrospinning B Démuth, A Farkas, H Pataki, A Balogh, B Szabó, E Borbás, PL Sóti, ... International journal of pharmaceutics 498 (1-2), 234-244, 2016 | 75 | 2016 |
| The effect of formulation additives on in vitro dissolution-absorption profile and in vivo bioavailability of telmisartan from brand and generic formulations E Borbás, Z Nagy,K, B Nagy, A Balogh, B Farkas, O Tsinman, K Tsinman, ... European Journal of Pharmaceutical Sciences 114, 310-317, 2018 | 68 | 2018 |
| Corona alternating current electrospinning: A combined approach for increasing the productivity of electrospinning B Farkas, A Balogh, R Cselkó, K Molnár, A Farkas, E Borbás, G Marosi, ... International journal of pharmaceutics 561, 219-227, 2019 | 65 | 2019 |
| Controlled-release solid dispersions of Eudragit® FS 100 and poorly soluble spironolactone prepared by electrospinning and melt extrusion A Balogh, B Farkas, A Domokos, A Farkas, B Démuth, E Borbás, B Nagy, ... European Polymer Journal 95, 406-417, 2017 | 64 | 2017 |
| Prediction of bioequivalence and food effect using flux-and solubility-based methods E Borbás, S Kádár, K Tsinman, O Tsinman, D Csicsák, K Takács-Novák, ... Molecular pharmaceutics 16 (10), 4121-4130, 2019 | 56 | 2019 |
| 3D floating tablets: Appropriate 3D design from the perspective of different in vitro dissolution testing methodologies K Ilyés, A Balogh, T Casian, T Igricz, E Borbás, B Démuth, P Vass, ... International journal of pharmaceutics 567, 118433, 2019 | 52 | 2019 |
| Electrospun amorphous solid dispersions of meloxicam: Influence of polymer type and downstream processing to orodispersible dosage forms T Casian, E Borbás, K Ilyés, B Démuth, A Farkas, Z Rapi, C Bogdan, ... International journal of pharmaceutics 569, 118593, 2019 | 51 | 2019 |
| The Effect of the Particle Size Reduction on the Biorelevant Solubility and Dissolution of Poorly Soluble Drugs with Different Acid-Base Character D Csicsák, R Szolláth, S Kádár, R Ambrus, C Bartos, E Balogh, I Antal, ... Pharmaceutics 15 (1), 278, 2023 | 43 | 2023 |
| Oral bioavailability enhancement of flubendazole by developing nanofibrous solid dosage forms T Vigh, B Démuth, A Balogh, DL Galata, I Van Assche, C Mackie, ... Drug development and industrial pharmacy 43 (7), 1126-1133, 2017 | 35 | 2017 |
| Towards a better understanding of the post-gastric behavior of enteric-coated formulations MT Katona, M Kakuk, R Szabo, P Tonka-Nagy, K Takacs-Novak, E Borbás Pharmaceutical Research 39 (1), 201, 2022 | 25 | 2022 |
| Data fusion strategies for performance improvement of a Process Analytical Technology platform consisting of four instruments: An electrospinning case study T Casian, A Farkas, K Ilyés, B Démuth, E Borbás, L Madarász, Z Rapi, ... International Journal of Pharmaceutics 567, 118473, 2019 | 25 | 2019 |
| Effect of formulation additives on drug transport through size-exclusion membranes E Borbás, P Tőzsér, K Tsinman, O Tsinman, K Takács-Novák, G Völgyi, ... Molecular pharmaceutics 15 (8), 3308-3317, 2018 | 25 | 2018 |
| Inclusion complexation of the anticancer drug pomalidomide with cyclodextrins: fast dissolution and improved solubility ZI Szabó, G Orbán, E Borbás, D Csicsák, S Kádár, B Fiser, M Dobó, ... Heliyon 7 (7), 2021 | 22 | 2021 |
